Thermo Fisher Scientific (TMO) Tax Provisions (2009 - 2026)

Thermo Fisher Scientific has reported Tax Provisions for 18 years, with the latest figure at $167.0 million in Q2 2026.

• Tax Provisions for Q2 2026 came in at $167.0 million, up 81.52% year-over-year; the trailing twelve-month figure through Jun 2026 was $597.0 million (up 36.93% YoY), and the FY2025 annual result was $547.0 million, down 16.74% from the prior year.
• Tax Provisions climbed to $167.0 million in Q2 2026, from $70.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $301.0 million in Q2 2022 and troughed at $31.0 million in Q4 2022.
• A 5-year average of $134.9 million and a median of $130.5 million in 2023 frame the typical range for Tax Provisions.
• The widest annual swing landed in 2022, when Tax Provisions tumbled 88.56%; it then jumped 510.87% in 2024.
• A 5-year view of Tax Provisions shows it stood at $173.0 million in 2022, then retreated by 23.12% to $133.0 million in 2023, then rose by 12.78% to $150.0 million in 2024, then grew by 2.0% to $153.0 million in 2025, then increased by 9.15% to $167.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $167.0 million in Q2 2026, $70.0 million in Q1 2026, and $153.0 million in Q4 2025.